Colonial Trust Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39K Hold
25
﹤0.01% 723
2026
Q1
$2.41K Hold
25
﹤0.01% 653
2025
Q4
$2.43K Buy
+25
New +$2.15K ﹤0.01% 630

Other funds holding IRMD

Colonial Trust Advisors's IRMD Position: Q2 2026 in Review

Colonial Trust Advisors held its iRadimed (IRMD) position steady in Q2 2026 at 25 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #723.

Colonial Trust Advisors first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.43K in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Colonial Trust Advisors held 25 shares of iRadimed worth $2.39K as of Q2 2026.
  • Colonial Trust Advisors left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q2 2026, its #723 holding.
  • Colonial Trust Advisors first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Colonial Trust Advisors's iRadimed position peaked at $2.43K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Colonial Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.